uracil has been researched along with Cancer of Esophagus in 27 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with squamous cell carcinoma or adenocarcinoma of the esophagus initially received UFT/leucovorin, carboplatin, and paclitaxel with RT (1." | 5.13 | A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. ( Bendell, JC; Cohen, DP; Czito, BG; D'Amico, TA; Hurwitz, HI; Kelsey, CR; Lockhart, AC; Petros, WP; Truax, R; Willett, CG, 2008) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "No effective treatment for advanced esophageal cancer extending to adjacent organs or associated with distant metastasis is known." | 2.71 | Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy. ( Horiuchi, Y; Indo, T; Iwase, H; Iyo, T; Kaida, S; Kato, E; Kusugami, K; Nakamura, M; Nakarai, K; Shimada, M, 2003) |
| "Ten patients with resectable esophageal cancer were enrolled." | 2.71 | Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. ( Beauchamp, RD; Berlin, J; Blanke, CD; Caillouette, C; Chakravarthy, B; Choy, H; Leach, S; Roberts, J; Shyr, Y; Tarpley, J; Tedesco, KL; Teng, M; Wyman, K, 2005) |
| "Although there are many randomized clinical trials of late course accelerated hyperfractionated radiotherapy (LCAHFR) combined with FP chemotherapy for esophageal cancer, the efficacy and toxicity are controversial." | 2.46 | Meta-analysis of late course accelerated hyperfractionated radiotherapy combined with FP chemotherapy for esophageal carcinoma. ( Gao, XS; Li, XY; Liu, CX, 2010) |
| "We present a case of esophageal cancer with multiple lymph node metastases successfully performed early response evaluation for preoperative chemotherapy by FDG-PET." | 1.35 | [Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET]. ( Arakaki, K; Isa, T; Kaneshiro, T; Nakachi, A; Nishimaki, T; Shiroma, H; Teruya, T; Yamamoto, H, 2008) |
| "Thirty-seven patients with advanced esophageal cancer were admitted between March 2002 and April 2005." | 1.34 | Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer. ( Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sung, HJ, 2007) |
| "A 65-year-old man was diagnosed as esophageal cancer with multiple liver metastases (S2 10 mm, S7 10 mm, S8 15 mm)." | 1.33 | [A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy]. ( Doi, K; Furuhashi, S; Ishihara, A; Ishimoto, T; Kikuchi, N; Ogata, K; Ogawa, M; Ohchi, T, 2006) |
| "A 77-year-old man with advanced esophageal cancer with tracheal and esophageal obstruction underwent continuous low-dose FP chemotherapy for a total of seven weeks, resulting in a complete response (CR) and disappearance of the esophago-tracheal fistula." | 1.31 | [A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer]. ( Hasebe, K; Sasaki, S; Takamura, H; Urade, M; Yagi, M, 2002) |
| "Thus, this case was diagnosed as esophageal cancer, but surgery was deemed inappropriate due to the patient's advanced age." | 1.30 | [A case of esophageal cancer with excellent response to oral UFT treatment]. ( Haga, S; Hirai, M; Kajiwara, T; Naritaka, Y; Ogawa, K; Otani, Y, 1999) |
| "Specimens from six clinical cases of esophageal cancer were transplanted under the renal capsule of AF nude mice, and chemosensitivity to anticancer drugs (UFT, CDDP) was evaluated by measuring tumor size (SRC)." | 1.29 | [Light and electron microscopic examination compared to evaluation by tumor size in subrenal capsule assay for chemosensitivity testing in esophageal cancer]. ( Akao, S; Ishikawa, H; Kiumi, F; Oya, M, 1995) |
| "Evaluability of gastric and breast cancers was very low because of the poor growth of the grafts irrespective of the immunity of host animals." | 1.29 | [Evaluation of subrenal capsule assay (SRC) for clinical cancers]. ( Akao, S; Ishikawa, H; Iwami, N; Kiumi, F; Oya, M; Sasaki, K; Terada, H, 1996) |
| "Thirty-five consecutive esophageal cancer patients were treated by a combination regimen COPU (CTX 600-800 mg/m2, IV, on days 1, 8, 15 at 8 PM; VCR 1." | 1.28 | [COPU regimen in the treatment of 35 esophageal cancers]. ( Qi, WB, 1989) |
| "We report two patients with esophageal cancer who responded to UFT." | 1.27 | [UFT in esophageal cancer: a report of two cases]. ( Kagami, Y; Narimatsu, N; Nishio, M; Saitoh, A; Sakurai, T, 1987) |
| "These were; EH-1 established from esophageal cancer, SH-6 from gastric cancer and CH-3 from colon cancer." | 1.27 | Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests. ( Hattori, T; Hirabayashi, N; Niimi, K; Niimoto, M; Nishiyama, M; Saeki, T; Takagami, S; Wang, DC; Yamaguchi, M; Yoshinaka, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (22.22) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, PQ | 1 |
| Dolley, A | 1 |
| Cheung, WY | 1 |
| Isa, T | 1 |
| Kaneshiro, T | 1 |
| Yamamoto, H | 1 |
| Nakachi, A | 1 |
| Teruya, T | 1 |
| Shiroma, H | 1 |
| Arakaki, K | 1 |
| Nishimaki, T | 1 |
| Liu, CX | 1 |
| Li, XY | 1 |
| Gao, XS | 1 |
| Holländer, C | 1 |
| Baeksgaard, L | 1 |
| Sorensen, M | 1 |
| Albertsson, P | 1 |
| Damstrup, L | 1 |
| Lassen, U | 1 |
| Takamura, H | 1 |
| Sasaki, S | 1 |
| Hasebe, K | 1 |
| Urade, M | 1 |
| Yagi, M | 1 |
| Iwase, H | 1 |
| Shimada, M | 1 |
| Nakamura, M | 1 |
| Nakarai, K | 1 |
| Iyo, T | 1 |
| Kaida, S | 1 |
| Indo, T | 1 |
| Kato, E | 1 |
| Horiuchi, Y | 1 |
| Kusugami, K | 1 |
| Akagi, Y | 1 |
| Hashimoto, Y | 1 |
| Takiyama, W | 1 |
| Mukaida, H | 1 |
| Murakami, Y | 1 |
| Ito, K | 1 |
| Tedesco, KL | 1 |
| Berlin, J | 1 |
| Blanke, CD | 1 |
| Teng, M | 1 |
| Choy, H | 1 |
| Roberts, J | 1 |
| Beauchamp, RD | 1 |
| Leach, S | 1 |
| Wyman, K | 1 |
| Tarpley, J | 1 |
| Shyr, Y | 1 |
| Caillouette, C | 1 |
| Chakravarthy, B | 1 |
| Ohchi, T | 1 |
| Kikuchi, N | 1 |
| Doi, K | 1 |
| Ogata, K | 1 |
| Ishimoto, T | 1 |
| Furuhashi, S | 1 |
| Ogawa, M | 1 |
| Ishihara, A | 1 |
| Shitara, K | 1 |
| Munakata, M | 1 |
| Ishiguro, A | 1 |
| Hoshi, Y | 1 |
| Okada, R | 1 |
| Tomioka, R | 1 |
| Mitobe, S | 1 |
| Sakata, Y | 1 |
| Ebina, A | 1 |
| Aoki, M | 1 |
| Choi, IK | 1 |
| Seo, HY | 1 |
| Sung, HJ | 1 |
| Park, KH | 1 |
| Kim, SJ | 1 |
| Oh, SC | 1 |
| Seo, JH | 1 |
| Choi, CW | 1 |
| Kim, BS | 1 |
| Shin, SW | 1 |
| Kim, YH | 1 |
| Kim, JS | 1 |
| Seike, J | 1 |
| Yoshida, T | 1 |
| Honda, J | 1 |
| Miyoshi, T | 1 |
| Umemoto, A | 1 |
| Tangoku, A | 1 |
| Czito, BG | 1 |
| Cohen, DP | 1 |
| Kelsey, CR | 1 |
| Lockhart, AC | 1 |
| Bendell, JC | 1 |
| Willett, CG | 1 |
| Petros, WP | 1 |
| D'Amico, TA | 1 |
| Truax, R | 1 |
| Hurwitz, HI | 1 |
| Akao, S | 2 |
| Oya, M | 2 |
| Ishikawa, H | 2 |
| Kiumi, F | 2 |
| Hashimoto, T | 1 |
| Omura, K | 1 |
| Ishida, F | 1 |
| Watanabe, Y | 1 |
| Iwami, N | 1 |
| Terada, H | 1 |
| Sasaki, K | 1 |
| Otani, Y | 1 |
| Hirai, M | 1 |
| Naritaka, Y | 1 |
| Haga, S | 1 |
| Ogawa, K | 1 |
| Kajiwara, T | 1 |
| Ohsawa, H | 1 |
| Aiba, K | 1 |
| Sugiyama, K | 1 |
| Mizunuma, N | 1 |
| Takahashi, S | 1 |
| Ito, Y | 1 |
| Horikoshi, N | 1 |
| Hamabe, Y | 1 |
| Ikuta, H | 1 |
| Osawa, M | 1 |
| Kuroda, D | 1 |
| Usami, M | 1 |
| Katoh, M | 1 |
| Saitoh, Y | 1 |
| Hazama, S | 1 |
| Hayashi, H | 1 |
| Oka, M | 1 |
| Murakami, T | 1 |
| Suzuki, T | 1 |
| Qi, WB | 1 |
| Monakhov, BV | 1 |
| Kolycheva, NI | 1 |
| Abisatov, KhA | 1 |
| Dzhumashev, EZ | 1 |
| Iunusova, SN | 1 |
| Nasipov, SN | 1 |
| Kenzhaliev, KhK | 1 |
| Kagami, Y | 1 |
| Sakurai, T | 1 |
| Nishio, M | 1 |
| Narimatsu, N | 1 |
| Saitoh, A | 1 |
| Nishiyama, M | 1 |
| Niimi, K | 1 |
| Takagami, S | 1 |
| Hirabayashi, N | 1 |
| Yamaguchi, M | 1 |
| Saeki, T | 1 |
| Yoshinaka, K | 1 |
| Wang, DC | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
3 reviews available for uracil and Cancer of Esophagus
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Meta-analysis of late course accelerated hyperfractionated radiotherapy combined with FP chemotherapy for esophageal carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bronchitis; Carcinoma, Squamous Cell | 2010 |
[Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell | 2004 |
6 trials available for uracil and Cancer of Esophagus
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2012 |
Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combi | 2003 |
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 2005 |
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2008 |
[Clinical trial of UFT in malignancies--an analysis of 337 patients. Co-operative Group for Clinical Study of UFT].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1986 |
19 other studies available for uracil and Cancer of Esophagus
| Article | Year |
|---|---|
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada.
Topics: Adult; Aged; Canada; Colorectal Neoplasms; Esophageal Neoplasms; Esophagogastric Junction; Frontotem | 2022 |
[Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 2008 |
[A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Resp | 2002 |
[A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 2006 |
[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administr | 2006 |
Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2007 |
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
Topics: Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combi | 2007 |
[Light and electron microscopic examination compared to evaluation by tumor size in subrenal capsule assay for chemosensitivity testing in esophageal cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esopha | 1995 |
[Clinical efficacy of cis-diamminedichloroplatinum [II] and 5-fluorouracil (UFT) in advanced cancer of the alimentary tract].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Drug Admi | 1993 |
[Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy | 1996 |
[A case of esophageal cancer with excellent response to oral UFT treatment].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug | 1999 |
[Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 1999 |
[A case of complete remission of lymph nodes metastasis from esophageal cancer with combination treatment of UFT and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 1992 |
[Regional immunochemotherapy for liver metastasis of esophageal cancer in a patient with variant hepatic artery].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 1991 |
[COPU regimen in the treatment of 35 esophageal cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cy | 1989 |
[Clinical prevention of esophageal cancer].
Topics: Combined Modality Therapy; Esophageal Neoplasms; Esophagitis, Peptic; Esophagoscopy; Esophagus; Foll | 1986 |
[Evaluation of the efficacy of the dispensary treatment of patients with chronic esophageal diseases (based on the data from a 10-year dynamic observation)].
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Esophageal Diseases; Esophageal Neoplasms; Evaluation | 1987 |
[UFT in esophageal cancer: a report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms | 1987 |
Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Transformed; Colonic Neoplasms; | 1988 |